serous adenocarcinoma

基本解釋

Methods Use flow cytometry and immunohistochemistry method to study 16 cases ovary serous adenocarcinoma and 4 cases normal ovary tissue.
方法採(cǎi)用流式細(xì)胞學(xué)和免疫組織化學(xué)方法對(duì)16例卵巢漿液性囊腺癌及4例正常卵巢組織進(jìn)行了研究。
Purpose To analyze the expression of thyroid transcription factor-1 (TTF-1) in the metastatic pulmonary adenocarcinoma cells in serous effusions.
目的探討甲狀腺轉(zhuǎn)錄因子1（TTF 1）在漿膜腔積液肺腺癌細(xì)胞中的表達(dá)，爲(wèi)肺腺癌的診斷和鋻別診斷提供新的依據(jù)。
Among patients with serous adenocarcinoma, 5-year survival was 61% and 31% for patients who did and did not undergo lymphadenectomy, respectively(P0.01).
卵巢漿液性癌，行與未行腹膜後淋巴結(jié)切除術(shù)患者的5年生存率分別爲(wèi)61%、3 1% （P0 0 1）。